GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).

With the launch of Polident, which is the global market leader in the denture care, the company has reinforced its presence in the overall oral health category in India, GSK Consumer Healthcare ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. While it ...

GSK’s ViiV Healthcare has shared clinical data on three potential long-acting HIV treatments, providing a look at how its ...

GSK), formerly known as GlaxoSmithKline, is a global pharmaceutical and healthcare corporation based in the United Kingdom that creates and distributes a variety of medications, vaccines, and consumer ...

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

GSK Plc is a long-term underperformer among ... Shares in the British drugmaker have fallen about 19% since it spun off its consumer health business in 2022, a move that activists had supported.

Discover GSK's impressive stock surge, boosted by strong earnings, a share buyback program, and a focus on specialty medicines.

GSK) stands against the other pharmaceutical stocks. Almost no other industry goes as far as the phrase "defensive" as the healthcare sector, which encompasses a wide range of companies that ...